359 related articles for article (PubMed ID: 14693683)
1. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion.
Gonon AT; Erbas D; Bröijersén A; Valen G; Pernow J
Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1767-74. PubMed ID: 14693683
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective effect of an endothelin receptor antagonist during ischaemia/reperfusion in the severely atherosclerotic mouse heart.
Gonon AT; Bulhak A; Bröijersén A; Pernow J
Br J Pharmacol; 2005 Mar; 144(6):860-6. PubMed ID: 15685207
[TBL] [Abstract][Full Text] [Related]
3. Bosentan, the mixed ETA-ETB endothelin receptor antagonist, attenuated oxidative stress after experimental myocardial ischemia and reperfusion.
Gupta SK; Saxena A; Singh U; Arya DS
Mol Cell Biochem; 2005 Jul; 275(1-2):67-74. PubMed ID: 16335785
[TBL] [Abstract][Full Text] [Related]
4. Contribution of NO to ischemia-reperfusion injury in the saline-perfused heart: a study in endothelial NO synthase knockout mice.
Flögel U; Decking UK; Gödecke A; Schrader J
J Mol Cell Cardiol; 1999 Apr; 31(4):827-36. PubMed ID: 10329210
[TBL] [Abstract][Full Text] [Related]
5. The role of the L-arginine/nitric oxide pathway in myocardial ischaemic and reperfusion injury.
Pernow J; Wang QD
Acta Physiol Scand; 1999 Oct; 167(2):151-9. PubMed ID: 10571551
[TBL] [Abstract][Full Text] [Related]
6. Interaction of nitric oxide and endothelin-1 in ischemia/reperfusion injury of rat heart.
Brunner F
J Mol Cell Cardiol; 1997 Sep; 29(9):2363-74. PubMed ID: 9299360
[TBL] [Abstract][Full Text] [Related]
7. Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts.
du Toit EF; McCarthy J; Miyashiro J; Opie LH; Brunner F
Br J Pharmacol; 1998 Mar; 123(6):1159-67. PubMed ID: 9559900
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotection by cyclosporine A in experimental ischemia and reperfusion--evidence for a nitric oxide-dependent mechanism mediated by endothelin.
Massoudy P; Zahler S; Kupatt C; Reder E; Becker BF; Gerlach E
J Mol Cell Cardiol; 1997 Feb; 29(2):535-44. PubMed ID: 9140813
[TBL] [Abstract][Full Text] [Related]
9. Role of nitric oxide and free radicals in cardioprotection by blocking Na+/H+ and Na+/Ca2+ exchange in rat heart.
Maczewski M; Beresewicz A
Eur J Pharmacol; 2003 Feb; 461(2-3):139-47. PubMed ID: 12586209
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotection from ischemia and reperfusion injury by an endothelin A-receptor antagonist in relation to nitric oxide production.
Gonon AT; Gourine AV; Pernow J
J Cardiovasc Pharmacol; 2000 Sep; 36(3):405-12. PubMed ID: 10975600
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of myocardial ischemia/reperfusion injury by superinduction of inducible nitric oxide synthase.
Kanno S; Lee PC; Zhang Y; Ho C; Griffith BP; Shears LL; Billiar TR
Circulation; 2000 Jun; 101(23):2742-8. PubMed ID: 10851213
[TBL] [Abstract][Full Text] [Related]
12. Effects of the non-peptide, non-selective endothelin antagonist, bosentan, on regional haemodynamic responses to NG-monomethyl-L-arginine in conscious rats.
Gardiner SM; Kemp PA; March JE; Bennett T
Br J Pharmacol; 1996 May; 118(2):352-4. PubMed ID: 8735637
[TBL] [Abstract][Full Text] [Related]
13. The dual effects of nitric oxide synthase inhibitors on ischemia-reperfusion injury in rat hearts.
Kobara M; Tatsumi T; Takeda M; Mano A; Yamanaka S; Shiraishi J; Keira N; Matoba S; Asayama J; Nakagawa M
Basic Res Cardiol; 2003 Sep; 98(5):319-28. PubMed ID: 12955405
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism.
Bradamante S; Barenghi L; Piccinini F; Bertelli AA; De Jonge R; Beemster P; De Jong JW
Eur J Pharmacol; 2003 Mar; 465(1-2):115-23. PubMed ID: 12650840
[TBL] [Abstract][Full Text] [Related]
15. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts.
Yasmin W; Strynadka KD; Schulz R
Cardiovasc Res; 1997 Feb; 33(2):422-32. PubMed ID: 9074708
[TBL] [Abstract][Full Text] [Related]
16. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
17. Protection against myocardial ischaemia/reperfusion injury by PPAR-alpha activation is related to production of nitric oxide and endothelin-1.
Bulhak AA; Sjöquist PO; Xu CB; Edvinsson L; Pernow J
Basic Res Cardiol; 2006 May; 101(3):244-52. PubMed ID: 16411023
[TBL] [Abstract][Full Text] [Related]
18. Short-acting calcium antagonist clevidipine protects against reperfusion injury via local nitric oxide-related mechanisms in the jeopardised myocardium.
Gourine A; Gonon A; Sjöquist PO; Pernow J
Cardiovasc Res; 2001 Jul; 51(1):100-7. PubMed ID: 11399252
[TBL] [Abstract][Full Text] [Related]
19. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release.
Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J
Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834
[TBL] [Abstract][Full Text] [Related]
20. Effects of nitric oxide synthase inhibition and endothelin ETA receptor blockade on haemodynamics in hypertensive rats.
Granstam SO; Lind L; Granstam E; Fellström B
Clin Exp Pharmacol Physiol; 1998 Sep; 25(9):693-701. PubMed ID: 9750958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
